rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Dennis Patrick Molnar

President

Company insider

Files Form 4 as: President, Apnimed.

In numbers

Trades disclosed
38
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
30 Jul 2026
Last trade
3 Aug 2026
Last filed
3 Aug 2026

Companies traded

Where they are an officer
APMD ApnimedOfficer · Biotechnology · last 3 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
3 Aug 2026filed 3 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code D—58,014filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—37,064 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—28,539 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—28,539 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—37,064 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—37,064 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—12,231 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—12,231 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—55,596 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—55,596 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code A—58,014filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—330,210 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—330,210 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—330,210 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—42,240 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—42,240 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—148,788 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—148,788 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code D—37,064 at $0.00filing
3 Aug 2026filed 3 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code A—37,064 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Alpha Wave Ventures GP, Ltd10% owner · 10% owner at Apnimed, filing Form 4 there in the last year
Morningside Venture Investments Ltd10% owner · 10% owner at Apnimed, filing Form 4 there in the last year
Gary SenderDirector · Director at Apnimed, filing Form 4 there in the last year
Kevin Robert LindDirector · Chief Executive Officer at Apnimed, filing Form 4 there in the last year
Paul R. FonteyneDirector · Director at Apnimed, filing Form 4 there in the last year